“Immune infusions are not a ready-made cocktail but are mixed individually for the patient after a detailed medical history ...

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

A new Day Infusion Unit (DIU) was officially opened at St Bernard’s hospital on Tuesday by the Minister for Health Gemma ...

Some elective or nonessential surgeries at Albany Medical Center’s hospitals have been delayed due to IV fluid shortages ...

The FDA approval of Selarsdi 130 mg/26 ml in a single-dose vial for intravenous infusion expands the label to include ...

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance ...

What you need to know Intravenous thrombolytics, including the recombinant tissue plasminogen activators alteplase or ...

华泰金融(HK)10月24日发布公告。SSY Group’s (SSY) 9M24 revenue/net profit (NP) were HKD4,534/919mn (-4.7/-2.8% yoy). The decline in profit was narrower than that in revenue for 9M24, mainly as: 1) on the revenue f ...

Dallas-based Community Infusion Solutions reported Oct. 21 successful results in clinical trials of its unique remote health ...

Hurricane Helene wrecked a Baxter International factory that produced 60 percent of the country’s IV fluids. Nearly 25,000 people who need IV nutrition are scrambling.

GRCE READ THE FULL GRCE RESEARCH REPORT We are initiating coverage of Grace Therapeutics, Inc. (NASDAQ:GRCE) with a valuation of $12.50 per share. This value is based on our estimates for the successf ...

Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports ...